Logo image of GENM.CA

GENERATION MINING LTD (GENM.CA) Stock Fundamental Analysis

TSX:GENM - CA37149B1094 - Common Stock

0.375 CAD
+0.04 (+11.94%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

1

Overall GENM gets a fundamental rating of 1 out of 10. We evaluated GENM against 796 industry peers in the Metals & Mining industry. GENM may be in some trouble as it scores bad on both profitability and health. GENM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GENM has reported negative net income.
In the past year GENM has reported a negative cash flow from operations.
GENM had negative earnings in each of the past 5 years.
GENM had a negative operating cash flow in each of the past 5 years.
GENM.CA Yearly Net Income VS EBIT VS OCF VS FCFGENM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

GENM has a worse Return On Assets (-455.08%) than 87.33% of its industry peers.
Industry RankSector Rank
ROA -455.08%
ROE N/A
ROIC N/A
ROA(3y)-190.5%
ROA(5y)-166.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENM.CA Yearly ROA, ROE, ROICGENM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

GENM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GENM.CA Yearly Profit, Operating, Gross MarginsGENM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

GENM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GENM has more shares outstanding
GENM has a worse debt/assets ratio than last year.
GENM.CA Yearly Shares OutstandingGENM.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
GENM.CA Yearly Total Debt VS Total AssetsGENM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

GENM has an Altman-Z score of -42.10. This is a bad value and indicates that GENM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -42.10, GENM is doing worse than 80.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -42.1
ROIC/WACCN/A
WACCN/A
GENM.CA Yearly LT Debt VS Equity VS FCFGENM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

2.3 Liquidity

A Current Ratio of 1.59 indicates that GENM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.59, GENM is in line with its industry, outperforming 49.94% of the companies in the same industry.
GENM has a Quick Ratio of 1.59. This is a normal value and indicates that GENM is financially healthy and should not expect problems in meeting its short term obligations.
GENM has a Quick ratio (1.59) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
GENM.CA Yearly Current Assets VS Current LiabilitesGENM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for GENM have decreased strongly by -35.95% in the last year.
EPS 1Y (TTM)-35.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, GENM will show a very strong growth in Earnings Per Share. The EPS will grow by 100.00% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y66.67%
EPS Next 2Y29.1%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GENM.CA Yearly EPS VS EstimatesGENM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GENM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GENM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GENM.CA Price Earnings VS Forward Price EarningsGENM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GENM.CA Per share dataGENM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

A more expensive valuation may be justified as GENM's earnings are expected to grow with 100.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3Y100%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GENM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENERATION MINING LTD

TSX:GENM (8/29/2025, 7:00:00 PM)

0.375

+0.04 (+11.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-10 2025-11-10
Inst Owners0.64%
Inst Owner ChangeN/A
Ins Owners6.34%
Ins Owner ChangeN/A
Market Cap100.57M
Analysts82.86
Price Target1.02 (172%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)100%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -455.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-190.5%
ROA(5y)-166.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z -42.1
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2.85%
Cap/Depr(5y)7.71%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-76.43%
EPS Next Y66.67%
EPS Next 2Y29.1%
EPS Next 3Y100%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.57%
EBIT Next 3Y8.74%
EBIT Next 5YN/A
FCF growth 1Y72.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.04%
OCF growth 3YN/A
OCF growth 5YN/A